Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06319300Not ApplicableRecruiting

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

Role: collaborator

NCT06078995Unknown

Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China

Role: collaborator

NCT04510532Unknown

Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic Resonance

Role: collaborator

NCT04973306Phase 2Recruiting

Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

Role: collaborator

All 4 trials loaded